Chinese investment firm Yingke PE on Thursday announced the final close of a new RMB-denominated fund at 10 billion yuan ($1.6 billion) as the firm builds a war chest to deploy capital in biomedicine and hard technology sectors.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
